|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-11-2
|
|
pubmed:abstractText |
Following publication of the Women's Health Initiative (WHI) study, many women discontinued use of estrogen replacement therapy. There is some evidence that the antihypertensive agent clonidine can reduce the frequency of hot flashes associated with menopause.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1198-581X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e191-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15520472-Aged,
pubmed-meshheading:15520472-Antihypertensive Agents,
pubmed-meshheading:15520472-Clonidine,
pubmed-meshheading:15520472-Drug Utilization,
pubmed-meshheading:15520472-Female,
pubmed-meshheading:15520472-Hot Flashes,
pubmed-meshheading:15520472-Humans,
pubmed-meshheading:15520472-Male,
pubmed-meshheading:15520472-Ontario,
pubmed-meshheading:15520472-Postmenopause,
pubmed-meshheading:15520472-Retrospective Studies,
pubmed-meshheading:15520472-Women's Health
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The impact of the Women's Health Initiative study on incident clonidine use in Ontario, Canada.
|
|
pubmed:affiliation |
Institute of Clinical Evaluative Sciences, Department of Public Health Sciences, University of Toronto. peter.austin@ices.on.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
